2-Methoxyestradiol synergizes with Erlotinib to suppress hepatocellular carcinoma by disrupting the PLAGL2-EGFR-HIF-1/2α signaling loop

Publication date: Available online 20 May 2021Source: Pharmacological ResearchAuthor(s): Shufang Zheng, Jiaping Ni, Ying Li, Mingying Lu, Yuchen Yao, Haixin Guo, Meng Jiao, Tianle Jin, Haoying Zhang, Ansheng Yuan, Zhuo Wang, Yong Yang, Zhen Chen, Hongxi Wu, Weiwei Hu
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research